arrow
B

Benedito A. Carneiro

brown university
H指数:40
被引数:9,176

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

16 ABBV-CLS-484: A Novel Oral PTPN2/1 Inhibitor for Cancer Immunotherapy

16 ABBV-CLS-484:一种新型口服PTPN2/1抑制剂用于癌症免疫疗法

2026-09-020
OAAI
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial

Elraglusib与化疗在转移性胰腺导管腺癌中的应用:一项随机对照二期临床试验

2026-04-140
OAAI
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

BrUOG360:一项关于Copanlisib联合Rucaparib治疗转移性去势抵抗性前列腺癌(mCRPC)患者的Ib/II期研究

2025-12-010
OA
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer

II期研究评估elraglusib(9-ING-41),一种GSK-3β抑制剂,与吉西他滨联合nab-紫杉醇用于既往未治疗的转移性胰腺癌。

2025-06-010
OA
Individualised schedule optimisation improves rates and severity of anaemia in patients ( pts) treated with lunresertib (lunre), a PKMYT1 inhibitor, and camonsertib (cam), an ATR inhibitor, in the phase I MYTHIC study (NCT0485565)
2024-10-010
PRE
Targeting apoptotic pathways for cancer therapy
2024-07-154
OAAI
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
2024-05-062
OAAI